Defunct Company
Total Trials
4
As Lead Sponsor
As Collaborator
0
Total Enrollment
427
NCT00634413
Effect of ADC4022 Co-Administered With Budesonide on Pulmonary Inflammation in Subjects With Moderate to Severe COPD
Phase: Phase 2
Role: Lead Sponsor
Start: Feb 29, 2008
Completion: Jan 31, 2009
NCT01173770
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ADC3680B in Healthy Volunteers
Phase: Phase 1
Start: Jul 31, 2010
Completion: Feb 28, 2011
NCT01448954
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of ADC3680B in Subjects With Partly Controlled Atopic Asthma
Start: Sep 30, 2011
Completion: Feb 29, 2012
NCT01730027
A Study to Evaluate Efficacy and Safety of ADC3680 in Subjects With Inadequately-Controlled Asthma
Start: Apr 30, 2013
Completion: Dec 31, 2014